PDF下载 ( 787 KB)
酒精性肝硬化患者的营养评估与管理
DOI: 10.12449/JCH250424
利益冲突声明：本文不存在任何利益冲突。
作者贡献声明：王立杰、杨颜榕负责查阅资料，撰写论文，二者对本文贡献等同，同为第一作者；董金玲、陈煜负责指导撰写文章、修改文章并最后定稿。
Evaluation and management of nutritional consequences in patients with alcoholic cirrhosis
-
摘要: 酒精性肝硬化患者多合并不同程度的营养不良，营养不良的患者更易出现感染、腹水等并发症，预后不佳。在临床工作中，对患者进行营养风险筛查尤为重要，使用合理的营养评估工具评定营养状态，制订个体化的营养补充方案，从而促进疾病恢复，改善患者预后及提高生活质量。本文阐述了酒精性肝硬化患者的营养筛查、评估及管理的具体方法，通过系统化的营养筛查和评估，可以早期识别出营养不良的患者，从而及时进行干预。个体化的营养补充方案需根据患者的情况进行调整，以满足其营养需求，促进肝功能的恢复和整体健康状况的改善，提升长期生活质量。Abstract: Patients with alcoholic cirrhosis often experience varying degrees of malnutrition， and the patients with malnutrition are more susceptible to complications such as infections and ascites， which may lead to a poor prognosis. Therefore， it is particularly important to conduct nutritional risk screening for patients in clinical practice， and appropriate nutritional assessment tools should be used to evaluate the nutritional status of patients and develop individualized nutritional supplementation regimens， thereby promoting disease recovery and improving prognosis and quality of life. This article elaborates on the specific methods for nutritional screening， assessment， and management in patients with alcoholic cirrhosis and points out that systematic nutritional screening and assessment can help to identify the patients with malnutrition in the early stage and provide timely intervention. Individualized nutritional supplementation regimens should be adjusted based on the conditions of patients， so as to meet their nutritional needs， promote the recovery of liver function， improve overall health status， and enhance long-term quality of life.
-
Key words:
- Liver Cirrhosis， Alcoholic /
- Malnutrition /
- Nutrition Assessment /
- Nutrition Therapy
-
[1] WU XQ, FAN XD, MIYATA T, et al. Recent advances in understanding of pathogenesis of alcohol-associated liver disease[J]. Annu Rev Pathol, 2023, 18: 411- 438. DOI: 10.1146/annurev-pathmechdis-031521-030435. [2] SAM J, NGUYEN GC. Protein-calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension[J]. Liver Int, 2009, 29( 9): 1396- 1402. DOI: 10.1111/j.1478-3231.2009.02077.x. [3] SUN JS, WANG BY. Treatment strategies of alcoholic hepatitis[J]. J Clin Hepatol, 2010, 26( 3): 260- 263. DOI: 10.3969/j.issn.1001-5256.2010.03.013.孙杰生, 王炳元. 酒精性肝炎的治疗策略[J]. 临床肝胆病杂志, 2010, 26( 3): 260- 263. DOI: 10.3969/j.issn.1001-5256.2010.03.013. [4] PENG S, PLANK LD, MCCALL JL, et al. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: A comprehensive study[J]. Am J Clin Nutr, 2007, 85( 5): 1257- 1266. DOI: 10.1093/ajcn/85.5.1257. [5] TANDON P, RAMAN M, MOURTZAKIS M, et al. A practical approach to nutritional screening and assessment in cirrhosis[J]. Hepatology, 2017, 65( 3): 1044- 1057. DOI: 10.1002/hep.29003. [6] ESPINA S, CASAS-DEZA D, BERNAL-MONTERDE V, et al. Evaluation and management of nutritional consequences of chronic liver diseases[J]. Nutrients, 2023, 15( 15): 3487. DOI: 10.3390/nu15153487. [7] BAN LW, YU SQ, HUA X, et al. Contrast analysis of nutritional status between patients of alcoholic cirrhosis and viral cirrhosis[J]. Parenter Enter Nutr, 2017, 24( 2): 105- 108. DOI: 10.16151/j.1007-810x.2017.02.012.班凌伟, 于淑清, 华鑫, 等. 酒精性肝硬化和病毒性肝硬化病人营养状况调查和分析[J]. 肠外与肠内营养, 2017, 24( 2): 105- 108. DOI: 10.16151/j.1007-810x.2017.02.012. [8] PLAUTH M, BERNAL W, DASARATHY S, et al. ESPEN guideline on clinical nutrition in liver disease[J]. Clin Nutr, 2019, 38( 2): 485- 521. DOI: 10.1016/j.clnu.2018.12.022. [9] KONDRUP J, RASMUSSEN HH, HAMBERG O, et al. Nutritional risk screening(NRS 2002): A new method based on an analysis of controlled clinical trials[J]. Clin Nutr, 2003, 22( 3): 321- 336. DOI: 10.1016/s0261-5614(02)00214-5. [10] BORHOFEN SM, GERNER C, LEHMANN J, et al. The royal free hospital-nutritional prioritizing tool is an independent predictor of deterioration of liver function and survival in cirrhosis[J]. Dig Dis Sci, 2016, 61( 6): 1735- 1743. DOI: 10.1007/s10620-015-4015-z. [11] BOOI AN, MENENDEZ J, JAMES NORTON H, et al. Validation of a screening tool to identify undernutrition in ambulatory patients with liver cirrhosis[J]. Nutr Clin Pract, 2015, 30( 5): 683- 689. DOI: 10.1177/0884533615587537. [12] WU YC, ZHU YG, FENG YL, et al. Royal Free Hospital-Nutritional Prioritizing Tool improves the prediction of malnutrition risk outcomes in liver cirrhosis patients compared with Nutritional Risk Screening 2002[J]. Br J Nutr, 2020, 124( 12): 1293- 1302. DOI: 10.1017/S0007114520002366. [13] CHI XP, REN XH, ZHANG YT, et al. The applicability of NRS2002 and RFH-NPT nutritional risk screening tools in hospitalized patients with decompensated liver cirrhosis[J/CD]. Chin J Liver Dis(Electronic Version), 2024, 16( 3): 65- 68. DOI: 10.3969/j.issn.1674-7380.2024.03.010.迟学彭, 任新华, 张耀庭, 等. NRS2002与RFH-NPT营养风险筛查工具对失代偿期肝硬化住院患者的适用性[J/CD]. 中国肝脏病杂志(电子版), 2024, 16( 3): 65- 68. DOI: 10.3969/j.issn.1674-7380.2024.03.010. [14] European Association for the Study of the Liver. EASL clinical practice guidelines on nutrition in chronic liver disease[J]. J Hepatol, 2019, 70( 1): 172- 193. DOI: 10.1016/j.jhep.2018.06.024. [15] WHITE JV, GUENTER P, JENSEN G, et al. Consensus statement: Academy of nutrition and dietetics and American society for parenteral and enteral nutrition: Characteristics recommended for the identification and documentation of adult malnutrition(undernutrition)[J]. JPEN J Parenter Enteral Nutr, 2012, 36( 3): 275- 283. DOI: 10.1177/0148607112440285. [16] ZHANG PY, WANG Q, ZHU MR, et al. Differences in nutritional risk assessment between NRS2002, RFH-NPT and LDUST in cirrhotic patients[J]. Sci Rep, 2023, 13( 1): 3306. DOI: 10.1038/s41598-023-30031-1. [17] CASAS-DEZA D, BERNAL-MONTERDE V, BETORÉ-GLARIA E, et al. Liver disease undernutrition screening tool questionnaire predicts decompensation and mortality in cirrhotic outpatients with portal hypertension[J]. Nutrients, 2023, 15( 17): 3780. DOI: 10.3390/nu15173780. [18] Chinese Society of Hepatology, Chinese Society of Gastroenterology, Chinese Medical Association. Clinical guidelines on nutrition in end-stage liver disease[J]. J Clin Hepatol, 2019, 35( 6): 1222- 1230. DOI: 10.3969/j.issn.1001-5256.2019.06.010.中华医学会肝病学分会, 中华医学会消化病学分会. 终末期肝病临床营养指南[J]. 临床肝胆病杂志, 2019, 35( 6): 1222- 1230. DOI: 10.3969/j.issn.1001-5256.2019.06.010. [19] WANG XY, FENG HJ, HUI YY, et al. Neutrophil-to-lymphocyte ratio is associated with malnutrition risk estimated by the Royal Free Hospital-Nutritional Prioritizing Tool in hospitalized cirrhosis[J]. JPEN J Parenter Enteral Nutr, 2022, 46( 1): 123- 129. DOI: 10.1002/jpen.2097. [20] JAVAID N, IQBAL AZ, HAMEEDA M. Nutritional management of liver cirrhosis and its complications in hospitalized patients[J]. Arq Gastroenterol, 2021, 58( 2): 246- 252. DOI: 10.1590/S0004-2803.202100000-43. [21] TANDON P, LOW G, MOURTZAKIS M, et al. A model to identify sarcopenia in patients with cirrhosis[J]. Clin Gastroenterol Hepatol, 2016, 14( 10): 1473- 1480. e 3. DOI: 10.1016/j.cgh.2016.04.040. [22] MAHARSHI S, SHARMA BC, SACHDEVA S, et al. Efficacy of nutritional therapy for patients with cirrhosis and minimal hepatic encephalopathy in a randomized trial[J]. Clin Gastroenterol Hepatol, 2016, 14( 3): 454- 460. e3; quize 33. DOI: 10.1016/j.cgh.2015.09.028. [23] HUANG HX, SHI XL, LI SH, et al. Sarcopenia-osteoporosis expert consensus[J]. Chin J Osteoporos, 2022, 28( 11): 1561- 1570. DOI: 10.3969/j.issn.1006-7108.2022.11.001.黄宏兴, 史晓林, 李盛华, 等. 肌少-骨质疏松症专家共识[J]. 中国骨质疏松杂志, 2022, 28( 11): 1561- 1570. DOI: 10.3969/j.issn.1006-7108.2022.11.001. [24] CAREY EJ, LAI JC, WANG CW, et al. A multicenter study to define sarcopenia in patients with end-stage liver disease[J]. Liver Transpl, 2017, 23( 5): 625- 633. DOI: 10.1002/lt.24750. [25] COELHO MPP, DINIZ KGD, BERING T, et al. Skeletal muscle mass index and phase angle are decreased in individuals with dependence on alcohol and other substances[J]. Nutrition, 2020, 71: 110614. DOI: 10.1016/j.nut.2019.110614. [26] WANG JH, LI J, FENG YM, et al. Energy metabolism and clinical features of patients with sub-acute-on-chronic alcoholic liver failure[J]. Beijing Med J, 2011, 33( 12): 970- 973. DOI: 10.15932/j.0253-9713.2011.12.017.王金环, 李娟, 冯岩梅, 等. 酒精性肝衰竭患者能量代谢与临床特点[J]. 北京医学, 2011, 33( 12): 970- 973. DOI: 10.15932/j.0253-9713.2011.12.017. [27] WANG JH, LI J, YU HW, et al. Energy metabolism and clinical features in patients with alcoholic cirrhosis[J]. Parenter Enter Nutr, 2014, 21( 4): 201- 204. DOI: 10.16151/j.1007-810x.2014.04.016.王金环, 李娟, 于红卫, 等. 酒精性肝硬化病人能量代谢和临床特点[J]. 肠外与肠内营养, 2014, 21( 4): 201- 204. DOI: 10.16151/j.1007-810x.2014.04.016. [28] da SILVA FINK J, DANIEL DE MELLO P, DANIEL DE MELLO E. Subjective global assessment of nutritional status-A systematic review of the literature[J]. Clin Nutr, 2015, 34( 5): 785- 792. DOI: 10.1016/j.clnu.2014.12.014. [29] MORGAN MY, MADDEN AM, SOULSBY CT, et al. Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis[J]. Hepatology, 2006, 44( 4): 823- 835. DOI: 10.1002/hep.21358. [30] RAMACHANDRAN G, POTTAKKAT B, MOHAN P, et al. Effectiveness of different tools for malnutrition in the assessment of patients with cirrhosis[J]. Am J Med Sci, 2024, 368( 1): 61- 67. DOI: 10.1016/j.amjms.2024.03.015. [31] KALAFATELI M, MANTZOUKIS K, CHOI YAU Y, et al. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score[J]. J Cachexia Sarcopenia Muscle, 2017, 8( 1): 113- 121. DOI: 10.1002/jcsm.12095. [32] YANG XY, CHEN L, PENG SF, et al. The value of RFH-NPT and RFH-GA on evaluating the nutritional status in patients with decompensated liver cirrhosis[J]. Chin J Clin Gastroenterol, 2022, 34( 2): 106- 110. DOI: 10.3870/lcxh.j.issn.1005-541X.2022.02.007.杨香瑜, 陈露, 彭随风, 等. RFH-NPT及RFH-GA在失代偿期肝硬化患者营养评估中的应用价值[J]. 临床消化病杂志, 2022, 34( 2): 106- 110. DOI: 10.3870/lcxh.j.issn.1005-541X.2022.02.007. [33] YU SQ, MENG QH, LI YX, et al. Energy metabolism in patients with chronic viral hepatitis and posthepatitic cirrhosis[J]. Chin J Gen Pract, 2007, 6( 10): 607- 610. DOI: 10.3760/cma.j.issn.1671-7368.2007.10.010.于淑清, 孟庆华, 李玉贤, 等. 慢性肝炎和肝炎后肝硬化患者能量代谢的研究[J]. 中华全科医师杂志, 2007, 6( 10): 607- 610. DOI: 10.3760/cma.j.issn.1671-7368.2007.10.010. [34] LEANDRO-MERHI VA, AQUINO JL. Investigation of nutritional risk factors using anthropometric indicators in hospitalized surgery patients[J]. Arq Gastroenterol, 2012, 49( 1): 28- 34. DOI: 10.1590/s0004-28032012000100006. [35] Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention. China Food Composition Table(Standard Edition, 6th Edition)[M]. Beijing: Peking University Medical Press, 2018.中国疾病预防控制中心营养与健康所. 中国食物成分表(标准版第6版)[M]. 北京: 北京大学医学出版社, 2018. [36] Expert Committee on Dietary Nutrient Reference Intakes 2023 of the Chinese Nutrition Society. Brief introduction to the 2023 Revised Edition of Chinese Dietary(DRIs)[J]. Acta Nutr Sin, 2023, 45( 6): 521- 524. DOI: 10.3969/j.issn.0512-7955.2023.06.001.中国营养学会膳食营养素参考摄入量专家委员会.《中国居民膳食营养素参考摄入量》2023修订版简介[J]. 营养学报, 2023, 45( 6): 521- 524. DOI: 10.3969/j.issn.0512-7955.2023.06.001. [37] MENDEZ-GUERRERO O, CARRANZA-CARRASCO A, LA CHI-CERVERA, et al. Optimizing nutrition in hepatic cirrhosis: A comprehensive assessment and care approach[J]. World J Gastroenterol, 2024, 30( 10): 1313- 1328. DOI: 10.3748/wjg.v30.i10.1313. [38] OWEN OE, TRAPP VE, REICHARD GA Jr, et al. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis[J]. J Clin Invest, 1983, 72( 5): 1821- 1832. DOI: 10.1172/JCI111142. [39] GUO YJ, TIAN ZB, JIANG N, et al. Effects of late evening snack on cirrhotic patients: A systematic review and meta-analysis[J]. Gastroenterol Res Pract, 2018, 2018: 9189062. DOI: 10.1155/2018/9189062. [40] NAKAYA Y, OKITA K, SUZUKI K, et al. BCAA-enriched snack improves nutritional state of cirrhosis[J]. Nutrition, 2007, 23( 2): 113- 120. DOI: 10.1016/j.nut.2006.10.008. [41] European Association for the Study of the Liver. EASL clinical practice guidelines: Management of alcohol-related liver disease[J]. J Hepatol, 2018, 69( 1): 154- 181. DOI: 10.1016/j.jhep.2018.03.018. [42] HOU W, WANG ZY, DONG JL, et al. Application of enteral nutrition and late evening snacks in patients with liver cirrhosis[J]. Clin Med J, 2019, 17( 4): 33- 37. DOI: 10.3969/j.issn.1672-3384.2019.04.008.侯维, 王忠英, 董金玲, 等. 肠内营养及睡前加餐在肝硬化患者中的应用效果评价[J]. 临床药物治疗杂志, 2019, 17( 4): 33- 37. DOI: 10.3969/j.issn.1672-3384.2019.04.008. [43] FIALLA AD, ISRAELSEN M, HAMBERG O, et al. Nutritional therapy in cirrhosis or alcoholic hepatitis: A systematic review and meta-analysis[J]. Liver Int, 2015, 35( 9): 2072- 2078. DOI: 10.1111/liv.12798. [44] MORENO C, DELTENRE P, SENTERRE C, et al. Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids[J]. Gastroenterology, 2016, 150( 4): 903- 910. e 8. DOI: 10.1053/j.gastro.2015.12.038. [45] MEENA BL, TANEJA S, TANDON P, et al. Home-based intensive nutrition therapy improves frailty and sarcopenia in patients with decompensated cirrhosis: A randomized clinical trial[J]. J Gastroenterol Hepatol, 2023, 38( 2): 210- 218. DOI: 10.1111/jgh.16035. [46] TADOKORO T, MORISHITA A, HIMOTO T, et al. Nutritional support for alcoholic liver disease[J]. Nutrients, 2023, 15( 6): 1360. DOI: 10.3390/nu15061360. [47] TANDON P, MONTANO-LOZA AJ, LAI JC, et al. Sarcopenia and frailty in decompensated cirrhosis[J]. J Hepatol, 2021, 75( Suppl 1): S147- S162. DOI: 10.1016/j.jhep.2021.01.025. [48] BISCHOFF SC, BERNAL W, DASARATHY S, et al. ESPEN practical guideline: Clinical nutrition in liver disease[J]. Clin Nutr, 2020, 39( 12): 3533- 3562. DOI: 10.1016/j.clnu.2020.09.001. [49] BUNCHORNTAVAKUL C, RAJENDER REDDY K. Review article: Malnutrition/sarcopenia and frailty in patients with cirrhosis[J]. Aliment Pharmacol Ther, 2020, 51( 1): 64- 77. DOI: 10.1111/apt.15571. [50] Beijing Medical Association, Committee of Parenteraland Enteral Nutrition; Expert Panel on Consensus on the parenteral and Enteral Nutritional and the Dietary Intervention for Patients with Chronic Liver Diseases. Consensus on the clinical nutritional intervention for patients with chronic liver diseases[J]. J Clin Hepatol, 2017, 33( 7): 1236- 1245. DOI: 10.3969/j.issn.1001-5256.2017.07.006.北京医学会肠外肠内营养学专业委员会,《慢性肝病患者肠外肠内营养支持与膳食干预专家共识》专家委员会. 慢性肝病患者肠外肠内营养支持与膳食干预专家共识[J]. 临床肝胆病杂志, 2017, 33( 7): 1236- 1245. DOI: 10.3969/j.issn.1001-5256.2017.07.006. [51] NAGEL M, LABENZ C, DOBBERMANN H, et al. Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation[J]. Eur J Gastroenterol Hepatol, 2022, 34( 10): 1053- 1059. DOI: 10.1097/MEG.0000000000002418. [52] YANG BB, HU CQ, HU YD, et al. Associations between vitamin D deficiency and alcoholic liver disease[J]. Acta Univ Med Anhui, 2019, 54( 8): 1273- 1276. DOI: 10.19405/j.cnki.issn1000-1492.2019.08.021.杨冰冰, 胡纯秋, 胡永迪, 等. 维生素D缺乏与酒精性肝病的相关性研究[J]. 安徽医科大学学报, 2019, 54( 8): 1273- 1276. DOI: 10.19405/j.cnki.issn1000-1492.2019.08.021. [53] OKUBO T, ATSUKAWA M, TSUBOTA A, et al. Effect of vitamin D supplementation on skeletal muscle volume and strength in patients with decompensated liver cirrhosis undergoing branched chain amino acids supplementation: A prospective, randomized, controlled pilot trial[J]. Nutrients, 2021, 13( 6): 1874. DOI: 10.3390/nu13061874. [54] CHAI BW, YANG YF, YANG YT, et al. Protective effect of nutrient complex on alcoholic liver disease rats and its mechanism[J]. J Jilin Univ Med Ed, 2019, 45( 6): 1256- 1260, 1481. DOI: 10.13481/j.1671-587x.20190611.柴博文, 杨岳峰, 杨野仝, 等. 营养素复合物对酒精性肝病大鼠的保护作用及其机制[J]. 吉林大学学报(医学版), 2019, 45( 6): 1256- 1260, 1481. DOI: 10.13481/j.1671-587x.20190611. [55] DINGWALL KM, DELIMA JF, BINKS P, et al. What is the optimum thiamine dose to treat or prevent Wernicke's encephalopathy or Wernicke-Korsakoff syndrome? Results of a randomized controlled trial[J]. Alcohol Clin Exp Res, 2022, 46( 6): 1133- 1147. DOI: 10.1111/acer.14843. [56] FUJIMOTO Y, KAJI K, NISHIMURA N, et al. Dual therapy with zinc acetate and rifaximin prevents from ethanol-induced liver fibrosis by maintaining intestinal barrier integrity[J]. World J Gastroenterol, 2021, 27( 48): 8323- 8342. DOI: 10.3748/wjg.v27.i48.8323. [57] SAKAMAKI A, YOKOYAMA K, KOYAMA K, et al. Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis[J]. PLoS One, 2020, 15( 11): e0242582. DOI: 10.1371/journal.pone.0242582. -
本文二维码
计量
- 文章访问数: 122
- HTML全文浏览量: 57
- PDF下载量: 19
- 被引次数: 0
下载:
